BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1
about
HLA-DR alpha 2 mediates negative signalling via binding to Tirc7 leading to anti-inflammatory and apoptotic effects in lymphocytes in vitro and in vivoEvolutionarily divergent herpesviruses modulate T cell activation by targeting the herpesvirus entry mediator cosignaling pathwayCTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanismsA coreceptor interaction between the CD28 and TNF receptor family members B and T lymphocyte attenuator and herpesvirus entry mediatorBTLA mediates inhibition of human tumor-specific CD8+ T cells that can be partially reversed by vaccinationB7x: a widely expressed B7 family member that inhibits T cell activationAgeing, autoimmunity and arthritis: Perturbations of TCR signal transduction pathways with ageing - a biochemical paradigm for the ageing immune systemEmerging mechanisms of immune regulation: the extended B7 family and regulatory T cellsThe quantal theory of how the immune system discriminates between "self and non-self"Beyond CTLA-4 and PD-1, the Generation Z of Negative Checkpoint RegulatorsBiomarkers for Sepsis: What Is and What Might Be?Autoimmune therapies targeting costimulation and emerging trends in multivalent therapeuticsThe role of the T follicular helper cells in allergic diseaseTransplantation tolerance and its outcome during infections and inflammationImmunotherapy in the treatment of non-small cell lung cancerBTLA interaction with HVEM expressed on CD8(+) T cells promotes survival and memory generation in response to a bacterial infectionRigid-body Ligand Recognition Drives Cytotoxic T-lymphocyte Antigen 4 (CTLA-4) Receptor TriggeringTargeting dendritic cell function during systemic autoimmunity to restore toleranceThe blockade of immune checkpoints in cancer immunotherapyThe DC-HIL/syndecan-4 pathway inhibits human allogeneic T-cell responsesCo-stimulatory pathways in lymphocyte regulation: the immunoglobulin superfamilyB and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediatorVstm3 is a member of the CD28 family and an important modulator of T-cell functionVSIG4, a B7 family-related protein, is a negative regulator of T cell activationGeneration and characterization of B7-H4/B7S1/B7x-deficient miceThe B7 family member B7-H3 preferentially down-regulates T helper type 1-mediated immune responsesImmunosuppressive strategies that are mediated by tumor cellsLymphatic endothelial cells induce tolerance via PD-L1 and lack of costimulation leading to high-level PD-1 expression on CD8 T cells.SHP-1 and SHP-2 in T cells: two phosphatases functioning at many levelsImmune response in silico (IRIS): immune-specific genes identified from a compendium of microarray expression data.Activation-induced accumulation of B and T lymphocyte attenuator at the immunological synapse in CD4+ T cells.Putting the brakes on BTLA in T cell-mediated cancer immunotherapyThe role of co-inhibitory signals in spontaneous tolerance of weakly mismatched transplantsB and T lymphocyte attenuator expression on CD4+ T-cells associates with sepsis and subsequent infections in ICU patients.Vasoactive intestinal peptide induces cell cycle arrest and regulatory functions in human T cells at multiple levels.T cell intrinsic heterodimeric complexes between HVEM and BTLA determine receptivity to the surrounding microenvironment.Constrained release of lamina-associated enhancers and genes from the nuclear envelope during T-cell activation facilitates their association in chromosome compartments.T follicular helper expansion and humoral-mediated rejection are independent of the HVEM/BTLA pathwayB and T lymphocyte attenuator tempers early infection immunityDendritic cell-regulatory T-cell interactions control self-directed immunity.
P2860
Q21562298-A428F7CF-DB3D-4337-999D-579A2EB0F6C5Q24532119-4EF8DB3F-A66F-48E3-8BE6-A1A7E0F6FEBEQ24534904-9BCCDBBB-29B7-4592-916D-0C7742D36B0EQ24557522-4AB199B3-9B5E-49F7-B4EE-AB1B0C69BAF4Q24652965-3C323063-34BE-4DC0-9639-81F39BF0EF4BQ24683252-B52D7FF1-B5E2-4443-9933-CE2CA8003C6EQ24795134-2113F10A-2B67-43EA-B675-7151956B21CEQ24796946-218607B7-BDF2-4967-9612-3E58C56509C0Q24803143-6C6FC198-2ABC-4CC5-BEDC-B4D7BA1B2B4CQ26782799-BA7F9C23-CE65-437A-B6E6-7FC702F225DFQ26785255-22DE3208-224B-4FCF-A6CC-652FCE3549C8Q26823789-386D6025-28DD-4237-96AA-130649842336Q26824290-0FF164AD-2A27-4321-B1E6-A00559FA8AFDQ26829817-C7A27618-C36D-4A19-9F71-98401981A96DQ27000382-45B1C269-E354-4340-B605-9EEFF1BAB775Q27303620-D561F43A-C4A7-4428-8818-D526B46CE4F0Q27666303-FF59C679-0F8C-4F8D-B4E4-0FF21A8E259EQ27687098-3A0EB8D5-EA35-49D4-8255-D00717D08348Q27860852-0B961EE7-9A35-49D1-B0F9-6E26542925A0Q28114771-4E53E5ED-310B-45FE-B3DF-A9216E4535B2Q28271806-58FAB498-F95B-42E8-89E4-EABA556FA889Q28506619-C52220EE-FF95-4F71-A32A-F13EF6B84B84Q28512622-58EFF248-3A28-4862-832F-CBD7DEB4DBE7Q28584882-34A680AB-981A-40B0-9AC8-3D019D5D36A4Q28585447-E116A3BF-9799-4C78-8DBA-BEAB3B1E02B0Q28594992-214D7AB3-C93E-42FA-A66F-BA5D7E3B4151Q29636247-81D29F92-80E8-461D-8134-CBA97A01FE28Q30415907-CAB596B2-A900-49CD-915E-57F1ACCAA0DDQ30436912-861C6C73-7BB5-45E9-8879-6568185F9211Q30985619-844B9E1A-C9C9-449E-B0C7-52E73844308FQ33515211-24F0BC28-DD76-4A14-A8C0-492D2239CBF6Q33559717-88034CDF-6F3C-4A34-8494-331AB9A281A7Q33648838-12CF0251-EC61-4426-8D85-5807041331DDQ33753374-B986A96C-C8E1-4C42-99D3-F683D59B6A5BQ33826520-02DAD009-69EB-4EE3-8362-1EADEF3E7F5FQ33832366-ED778855-112C-482C-9FB9-EFF97FA26E7CQ33865147-303CBF88-3372-4BC9-A286-CBC8F09672FEQ33920121-77AF5987-1993-4945-A31A-AC6B8FF73FB1Q33954000-88700B97-FD76-4CF5-B778-B8C177483159Q34004810-1204D714-4F61-4C30-8AE7-E8030C7A1122
P2860
BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1
description
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2003
@ast
im Juli 2003 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2003/07/01)
@sk
vědecký článek publikovaný v roce 2003
@cs
wetenschappelijk artikel (gepubliceerd op 2003/07/01)
@nl
наукова стаття, опублікована в липні 2003
@uk
مقالة علمية (نشرت في يوليو 2003)
@ar
name
BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1
@ast
BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1
@en
BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1
@nl
type
label
BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1
@ast
BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1
@en
BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1
@nl
prefLabel
BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1
@ast
BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1
@en
BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1
@nl
P2093
P2860
P50
P921
P3181
P356
P1433
P1476
BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1
@en
P2093
Jianfei Yang
John R. Sedy
Kenneth M. Murphy
Maya Gavrieli
Michelle A. Hurchla
Natalie Zimmerman
Norihiko Watanabe
Susan K. Loftin
Theresa L. Murphy
P2860
P304
P3181
P356
10.1038/NI944
P407
P577
2003-07-01T00:00:00Z